SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDsw Capital Regulatory News (DSW)

Share Price Information for Dsw Capital (DSW)

Share Price is delayed by 15 minutes
Get Live Data
42.50    -0.50 (-1.18%)
Bid:
40.00
Ask:
45.00
Spread: 5.00 (12.50%)
Market Cap: £10.56m
DSW Live PriceLast checked at - London Stock Exchange

Intraday Dsw Capital Share Chart

Board Changes & Succession Planning

25 Nov 2024 07:00

RNS Number : 3972N
DSW Capital PLC
25 November 2024
 

 

25 November 2024

 

DSW CAPITAL PLC

("DSW Capital", "DSW" or the "Group")

(AIM: DSW)

 

Board Changes and Succession Planning

DSW Capital, a profitable, mid-market, challenger professional services licence network and owner of the Dow Schofield Watts and DR Solicitors brands, announces the following board changes and details of its succession planning.

 

The board announces that, as part of the Group's succession planning, Shru Morris, who joined the Group as Deputy CEO in August 2024, has today been appointed CEO Designate.

 

Shru will succeed James Dow on 1 April 2025, when he steps down as CEO. Shru is a highly experienced finance professional and CEO with a strong background in professional services, specifically law. Her experience and expertise were instrumental in the delivery of DSW's transformational acquisition of DR Solicitors Limited, which completed last month.

 

James, who co-founded the business with Jon Schofield and Mark Watts in 2002, and spearheaded the Group's IPO strategy, will remain on the board, as Executive Director, with effect from 1 April 2025. He will continue to play a vital role in attracting new businesses and partners to the network, maintaining an Ambassadorial role for both DSW and our Pandea network, while providing ongoing strategic counsel to the management team.

 

The board also announces that Pete Fendall, the Group's COO and Interim CFO, has today been appointed Chief Finance and Operating Officer. Pete has been a key member of the senior management and finance team since before the IPO and has further impressed the board since his appointment as Interim CFO in May this year. He qualified as a Chartered Accountant with Deloitte in 2017 and spent eight years in Deloitte's NW Audit team, working on large and complex audit engagements, before joining DSW in 2021.

 

Heather Lauder, Chair of DSW, said:

 

"We are all delighted that Shru has agreed to lead the Group when James stands down as CEO in March next year, and that DSW will retain James' skills, knowledge and expertise in his role as Executive Director. The creation of DSW was truly pioneering and the first of its kind within professional services. DSW's vision has been, and remains, inspirational, and James has worked relentlessly to help others create successful businesses. DSW has never been stronger and, on behalf of everyone at the Group, I thank for his commitment in leading the business.

 

"Shru has already made a significant impact on the business in the short time since her appointment as Deputy CEO. Her energy and commitment to the Group and to furthering James' vision is positively tangible, and James hands the reins to a woman who shares his ability, vision and values.

 

"I would finally like to add what a pleasure it is to recognise the contribution Pete has made to the business, since joining us in 2021and, in particular, over the last six months; his appointment as Chief Finance and Operating Officer is thoroughly deserved.

 

"As a board, we look forward to a successful future under Shru and Pete's management and to supporting them in their new and future roles, as they work to further the Group's ambitions."

 

Online Investor Presentation

 

The management team will host an online H1 25 Results presentation for investors tomorrow, Tuesday 26 November 2024, at 3.00pm. Anyone wishing to join the presentation should register at https://bit.ly/DSW_H125_results_webinar.

Enquiries

 

DSW Capital

James Dow, CEO

Shru Morris, CEO Designate

Pete Fendall, CFOO

 

Tel: +44 (0) 1928 378 100

Shore Capital (Nominated Adviser & Broker)

James Thomas/Mark Percy/Rachel Goldstein (Corporate Advisory)

Guy Wiehahn / Isobel Jones (Corporate Broking)

 

Tel: +44 (0)20 7408 4090

Rawlings Financial PR Limited

Cat Valentine

dswcapital@rfpr.co.uk

Tel: +44 (0) 7715 769 078

 

About DSW Capital

 

DSW Capital, owner of the Dow Schofield Watts and DR Solicitors brands, is a profitable, mid-market, challenger professional services network with a cash generative business model and scalable platform for growth. Originally established in 2002, by three KPMG alumni, Dow Schofield Watts is one of the first platform models disrupting the traditional model of accounting professional services firms. DSW Capital operates licensing arrangements with its businesses and has over 130 fee earners across 12 offices in the UK. These businesses trade primarily under the Dow Schofield Watts and DR Solicitors brands.

 

DSW Capital's vision is for our brands to become the most sought-after destinations for ambitious, entrepreneurial professionals to start and develop their own businesses. Through a licensing model, DSW Capital gives professionals the autonomy and flexibility to fulfil their potential.

 

Being part of the DSW Capital group brings support benefits in recruitment, funding and infrastructure. DSW Capital's challenger model attracts experienced, senior professionals, predominantly with a "Big 4" accounting firm or "Magic Circle" legal background, who want to launch their own businesses and recognise the value of DSW Capital's brands and the synergies which come from being part of the network.

 

DSW Capital aims to scale its agile model through organic growth, geographical expansion, additional service lines and acquisitions. The Directors are targeting high margin, complementary, niche service lines with a strong synergistic fit with the existing network.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABTBFTMTITBAI
12
Date   Source Headline
3rd Jun 20262:26 pmRNSHolding(s) in Company
15th May 20267:00 amRNSTrading Update & Notice of Results
16th Mar 20267:00 amRNSTrading Update
16th Mar 20267:00 amRNSTrading Update
5th Jan 20269:17 amRNSHoldings in Company
24th Nov 20254:25 pmRNSHolding(s) in Company
24th Nov 20257:00 amRNSHalf Year Results
13th Nov 20257:00 amRNSHalf Year Trading Update and Notice of Results
7th Oct 20257:00 amRNS-RMello Investor Presentation
30th Sep 20257:00 amRNSHolding(s) in Company
29th Sep 20252:43 pmRNSDirector / PDMR Shareholding
16th Sep 202512:18 pmRNSResult of AGM
6th Aug 20257:00 amRNSGrant of options under Performance Share Plan
9th Jul 20251:45 pmRNSHolding(s) in Company
8th Jul 20257:00 amRNSFinal Results FY25
2nd Jul 20257:00 amRNS-RFY25 Results Presentation
15th May 20257:00 amRNSTrading Update and Notice of Results
17th Mar 20253:30 pmRNSHolding(s) in Company
7th Jan 202510:15 amRNSHolding(s) in Company
18th Dec 20243:29 pmRNSHolding(s) in Company
13th Dec 20244:56 pmRNSTR-1: Notification of Major Holdings
12th Dec 20247:00 amRNSHolding(s) in Company
11th Dec 20247:00 amRNSDirector/PDMR Shareholding
25th Nov 20247:00 amRNSGrant of awards under Performance Share Plan
25th Nov 20247:00 amRNSBoard Changes & Succession Planning
25th Nov 20247:00 amRNSHalf Year Results
7th Nov 20247:00 amRNSTrading Update, Notice of Results and Presentation
4th Nov 20247:00 amRNSAcquisition, Issue of Equity, RCF, and TVR
29th Oct 20247:00 amRNSDirectorate Change
24th Sep 20241:06 pmRNSResult of AGM
10th Jul 20249:35 amRNSGrant of awards under Performance Share Plan
10th Jul 20247:00 amRNSDirector/PDMR Shareholding
4th Jul 20247:00 amRNSDirector/PDMR Shareholding
2nd Jul 20247:00 amRNSAudited Final Results
11th Jun 20247:00 amRNSAppointment of Deputy CEO
15th May 20247:00 amRNSTrading Update and Notice of Final Results
2nd Apr 20247:00 amRNSAppointment of COO and Interim CFO
15th Feb 20247:00 amRNSTrading Update
17th Jan 20247:00 amRNSBoard Update
7th Dec 20234:30 pmRNSDirector/PDMR Shareholding
29th Nov 20237:00 amRNSDirector/PDMR Shareholding
27th Nov 20237:00 amRNSHalf Year Results
21st Nov 20237:00 amRNSHalf Year Online Results Presentation
9th Nov 20237:00 amRNSTrading Update and Notice of Results
11th Oct 20237:00 amRNSChange of role: CFO becomes Deputy CEO and CFO
4th Oct 20237:00 amRNSDSW adds a further new geographic location
29th Sep 20237:00 amRNSExpansion of DSW Tax Advisory capabilities
20th Sep 20237:00 amRNSNew Geographic Location for Corporate Finance
18th Sep 20232:33 pmRNSResult of AGM
18th Jul 20235:40 pmRNSDirector/PDMR Shareholding
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.